Involvement of Homologous Recombination in Carcinogenesis

Advances in Genetics

Volumn 58, Issue , 2007, Pages 67-87

  Reliene, Ramune ^a   Bishop, Alexander J R ^c   Schiestl, Robert H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ATM PROTEIN; BLOOM SYNDROME PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; FANCONI ANEMIA PROTEIN; HELICASE; PROTEIN SERINE THREONINE KINASE; RAD51 PROTEIN; RECQ HELICASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WRN PROTEIN, HUMAN;

ANIMAL; BIOLOGICAL MODEL; DNA REPAIR; GENETIC RECOMBINATION; GENETICS; HUMAN; NEOPLASM; PHYSIOLOGY; REVIEW; THEORETICAL MODEL; TUMOR SUPPRESSOR GENE;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CELL CYCLE PROTEINS; DNA HELICASES; DNA REPAIR; DNA-BINDING PROTEINS; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENES, BRCA1; GENES, BRCA2; GENES, P53; HUMANS; MODELS, BIOLOGICAL; MODELS, THEORETICAL; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RAD51 RECOMBINASE; RECOMBINATION, GENETIC; RECQ HELICASES; TUMOR SUPPRESSOR PROTEINS;

EID: 34247164462     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2660(06)58003-4     Document Type: Review

References (136)

1. Arnaudeau C., Helleday T., and Jenssen D. The RAD51 protein supports homologous recombination by an exchange mechanism in mammalian cells. J. Mol. Biol. 289 (1999) 1231-1238
2. Aubrecht J., Rugo R., and Schiestl R.H. Carcinogens induce intrachromosomal recombination in human cells. Carcinogenesis 16 (1995) 2841-2846
3. Aubrecht J., Secretan M.B., Bishop A.J., and Schiestl R.H. Involvement of p53 in X-ray induced intrachromosomal recombination in mice. Carcinogenesis 20 (1999) 2229-2236
4. Ballabio A., Bardoni B., Guioli S., Basler E., and Camerino G. Two families of low-copy-number repeats are interspersed on Xp22.3: Implications for the high frequency of deletions in this region. Genomics 8 (1990) 263-270
5. Barlow C., Dennery P.A., Shigenaga M.K., Smith M.A., Morrow J.D., Roberts II L.J., Wynshaw-Boris A., and Levine R.L. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci. USA 96 (1999) 9915-9919
6. Becker-Catania S.G., and Gatti R.A. Ataxia-telangiectasia. Adv. Exp. Med. Biol. 495 (2001) 191-198
7. Bertrand P., Rouillard D., Boulet A., Levalois C., Soussi T., and Lopez B.S. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein. Oncogene 14 (1997) 1117-1122
8. Bishop A.J.R., Barlow C., Wynshaw-Boris A.J., and Schiestl R.H. Atm deficiency causes an increased frequency of intrachromosomal homologous recombination in mice. Cancer Res. 60 (2000) 395-399
9. Bishop A.J.R., Kosaras B., Sidman R.L., and Schiestl R.H. Benzo(a)pyrene and X-rays induce reversions of the pink-eye unstable mutation in the retinal pigment epithelium of mice. Mutat. Res. 457 (2000) 31-40
10. Bishop A.J., Hollander M.C., Kosaras B., Sidman R.L., Fornace Jr. A.J., and Schiestl R.H. Atm-, p53-, and Gadd45a-deficient mice show an increased frequency of homologous recombination at different stages during development. Cancer Res. 63 (2003) 5335-5343
11. Bishop A.J., Kosaras B., Hollander M.C., Fornace Jr. A., Sidman R.L., and Schiestl R.H. p21 controls patterning but not homologous recombination in RPE development. DNA Repair 5 (2006) 111-120
12. Brennan R.J., and Schiestl R.H. Cadmium is an inducer of oxidative stress in yeast. Mutat. Res. 356 (1996) 171-178
13. Brennan R.J., and Schiestl R.H. Aniline and its metabolites generate free radicals in yeast. Mutagenesis 12 (1997) 215-220
14. Brennan R.J., and Schiestl R.H. Diaminotoluenes induce intrachromosomal recombination and free radicals in Saccharomyces cerevisiae. Mutat. Res. 381 (1997) 251-258
15. Brennan R.J., and Schiestl R.H. Chloroform and carbon tetrachloride induce intrachromosomal recombination and oxidative free radicals in Saccharomyces cerevisiae. Mutat. Res. 397 (1998) 271-278
16. Brennan R.J., and Schiestl R.H. Free radicals generated in yeast by the Salmonella test-negative carcinogens benzene, urethane, thiourea and auramine O. Mutat. Res. 403 (1998) 65-73
17. Brennan R.J., and Schiestl R.H. The aromatic amine carcinogens o-toluidine and o-anisidine induce free radicals and intrachromosomal recombination in Saccharomyces cerevisiae. Mutat. Res. 430 (1999) 37-45
18. Buchhop S., Gibson M.K., Wang X.W., Wagner P., Sturzbecher H.W., and Harris C.C. Interaction of p53 with the human Rad51 protein. Nucleic Acids Res. 25 (1997) 3868-3874
19. Calabretta B., Robberson D.L., Barrera-Saldana H.A., Lambrou T.P., and Saunders G.F. Genome instability in a region of human DNA enriched in Alu repeat sequences. Nature 296 (1982) 219-225
20. Carls N., and Schiestl R.H. Evaluation of the yeast DEL assay with 10 compounds selected by the International Program on Chemical Safety for the evaluation of short-term tests for carcinogens. Mutat. Res. 320 (1994) 293-303
21. Carreau M., Alon N., Bosnoyan-Collins L., Joenje H., and Buchwald M. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups. Mutat. Res. 435 (1999) 103-109
22. Carson C.T., Schwartz R.A., Stracker T.H., Lilley C.E., Lee D.V., and Weitzman M.D. The Mre11 complex is required for ATM activation and the G2/M checkpoint. EMBO J. 22 (2003) 6610-6620
23. Chance P.F., Alderson M.K., Leppig K.A., Lensch M.W., Matsunami N., Smith B., Swanson P.D., Odelberg S.J., Disteche C.M., and Bird T.D. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72 (1993) 143-151
24. Cohen M.M., and Levy H.P. Chromosome instability syndromes. Adv. Hum. Genet. 18 (1989) 43-149 365-371
25. Constantinou A., Tarsounas M., Karow J.K., Brosh R.M., Bohr V.A., Hickson I.D., and West S.C. Werner's syndrome protein (WRN) migrates Holliday junctions and co-localizes with RPA upon replication arrest. EMBO Rep. 1 (2000) 80-84
26. Davies R., Moore A., Schedl A., Bratt E., Miyahawa K., Ladomery M., Miles C., Menke A., van Heyningen V., and Hastie N. Multiple roles for the Wilms' tumor suppressor, WT1. Cancer Res. 59 (1999) 1747s-1750s discussion 1751s
27. Deans B., Griffin C.S., Maconochie M., and Thacker J. Xrcc2 is required for genetic stability, embryonic neurogenesis and viability in mice. EMBO J. 19 (2000) 6675-6685
28. de la Chapelle A., Herva R., Koivisto M., and Aula P. A deletion in chromosome 22 can cause DiGeorge syndrome. Hum. Genet. 57 (1981) 253-256
29. Digweed M., Rothe S., Demuth I., Scholz R., Schindler D., Stumm M., Grompe M., Jordan A., and Sperling K. Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis 23 (2002) 1121-1126
30. Donahue S.L., Lundberg R., Saplis R., and Campbell C. Deficient regulation of DNA double-strand break repair in Fanconi anemia fibroblasts. J. Biol. Chem. 278 (2003) 29487-29495
31. Ellis N.A., Groden J., Ye T.Z., Straughen J., Lennon D.J., Ciocci S., Proytcheva M., and German J. The Bloom's syndrome gene product is homologous to RecQ helicases. Cell 83 (1995) 655-666
32. Galli A., and Schiestl R.H. Effects of Salmonella assay negative and positive carcinogens on intrachromosomal recombination in G1-arrested yeast cells. Mutat. Res. 370 (1996) 209-221
33. Galli A., and Schiestl R.H. Cell division transforms mutagenic lesions into deletion-recombinagenic lesions in yeast cells. Mutat. Res. 429 (1999) 13-26
34. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., and D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7 (2001) 249-262
35. Gebow D., Miselis N., and Liber H.L. Homologous and nonhomologous recombination resulting in deletion: Effects of p53 status, microhomology, and repetitive DNA length and orientation. Mol. Cell. Biol. 20 (2000) 4028-4035
36. German J. Bloom syndrome: A mendelian prototype of somatic mutational disease. Medicine (Baltimore) 72 (1993) 393-406
37. Haber J.E. Partners and pathwaysrepairing a double-strand break. Trends Genet. 16 (2000) 259-264
38. Henning W., and Sturzbecher H.W. Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance. Toxicology 193 (2003) 91-109
39. Heppner G.H., and Miller F.R. The cellular basis of tumor progression. Int. Rev. Cytol. 177 (1998) 1-56
40. Hickson I.D., Davies S.L., Li J.L., Levitt N.C., Mohaghegh P., North P.S., and Wu L. Role of the Bloom's syndrome helicase in maintenance of genome stability. Biochem. Soc. Trans. 29 (2001) 201-204
41. Hyrien O. Mechanisms and consequences of replication fork arrest. Biochimie 82 (2000) 5-17
42. Imamura O., Fujita K., Itoh C., Takeda S., Furuichi Y., and Matsumoto T. Werner and Bloom helicases are involved in DNA repair in a complementary fashion. Oncogene 21 (2002) 954-963
43. Jackson S.P. Sensing and repairing DNA double-strand breaks. Carcinogenesis 23 (2002) 687-696
44. Jalili T., Murthy G.G., and Schiestl R.H. Cigarette smoke induces DNA deletions in the mouse embryo. Cancer Res. 58 (1998) 2633-2638
45. Ji Y., Eichler E.E., Schwartz S., and Nicholls R.D. Structure of chromosomal duplicons and their role in mediating human genomic disorders. Genome Res. 10 (2000) 597-610
46. Joenje H., and Patel K.J. The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet. 2 (2001) 446-457
47. Kamsler A., Daily D., Hochman A., Stern N., Shiloh Y., Rotman G., and Barzilai A. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res. 61 (2001) 1849-1854
48. Karow J.K., Constantinou A., Li J.L., West S.C., and Hickson I.D. The Bloom's syndrome gene product promotes branch migration of holliday junctions. Proc. Natl. Acad. Sci. USA 97 (2000) 6504-6508
49. Kim P.M., Allen C., Wagener B.M., Shen Z., and Nickoloff J.A. Overexpression of human RAD51 and RAD52 reduces double-strand break-induced homologous recombination in mammalian cells. Nucleic Acids Res. 29 (2001) 4352-4360
50. Knudson A.G. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA 90 (1993) 10914-10921
51. Knudson A.G. Two genetic hits (more or less) to cancer. Nat. Rev. Cancer 1 (2001) 157-162
52. Kojis T.L., Gatti R.A., and Sparkes R.S. The cytogenetics of ataxia telangiectasia. Cancer Genet. Cytogenet. 56 (1991) 143-156
53. Kovalchuk O., Hendricks C.A., Cassie S., Engelward A.J., and Engelward B.P. In vivo recombination after chronic damage exposure falls to below spontaneous levels in "recombomice.". Mol. Cancer Res. 2 (2004) 567-573
54. Kraakman-van der Zwet M., Overkamp W.J., van Lange R.E., Essers J., van Duijn-Goedhart A., Wiggers I., Swaminathan S., van Buul P.P., Errami A., Tan R.T., Jaspers N.G., Sharan S.K., et al. Brca2 (XRCC11) deficiency results in radioresistant DNA synthesis and a higher frequency of spontaneous deletions. Mol. Cell. Biol. 22 (2002) 669-679
55. Krogh B.O., and Symington L.S. Recombination proteins in yeast. Annu. Rev. Genet. 38 (2004) 233-271
56. Kuzminov A. DNA replication meets genetic exchange: Chromosomal damage and its repair by homologous recombination. Proc. Natl. Acad. Sci. USA 98 (2001) 8461-8468
57. Lavin M.F., and Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15 (1997) 177-202
58. Lebel M. Increased frequency of DNA deletions in pink-eyed unstable mice carrying a mutation in the Werner syndrome gene homologue. Carcinogenesis 23 (2002) 213-216
59. Ledbetter D.H., Riccardi V.M., Airhart S.D., Strobel R.J., Keenan B.S., and Crawford J.D. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N. Engl. J. Med. 304 (1981) 325-329
60. Lehrman M.A., Schneider W.J., Sudhof T.C., Brown M.S., Goldstein J.L., and Russell D.W. Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains. Science 227 (1985) 140-146
61. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
62. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
63. Li F.P., and Fraumeni Jr. J.F. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?. Ann. Intern. Med. 71 (1969) 747-752
64. Lim D.S., and Hasty P. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 16 (1996) 7133-7143
65. Livingstone L.R., White A., Sprouse J., Livanos E., Jacks T., and Tlsty T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70 (1992) 923-935
66. Loeb K.R., and Loeb L.A. Significance of multiple mutations in cancer. Carcinogenesis 21 (2000) 379-385
67. Lohmann D.R. RB1 gene mutations in retinoblastoma. Hum. Mutat. 14 (1999) 283-288
68. Lupski J.R. Genomic disorders: Structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet. 14 (1998) 417-422
69. Maacke H., Opitz S., Jost K., Hamdorf W., Henning W., Kruger S., Feller A.C., Lopens A., Diedrich K., Schwinger E., et al. Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer. Int. J. Cancer 88 (2000) 907-913
70. Maacke H., Jost K., Opitz S., Miska S., Yuan Y., Hasselbach L., Luttges J., Kalthoff H., and Sturzbecher H.W. DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene 19 (2000) 2791-2795
71. Macleod K. Tumor suppressor genes. Curr. Opin. Genet. Dev. 10 (2000) 81-93
72. Marmorstein L.Y., Ouchi T., and Aaronson S.A. The BRCA2 gene product functionally interacts with p53 and RAD51. Proc. Natl. Acad. Sci. USA 95 (1998) 13869-13874
73. Mazzarella R., and Schlessinger D. Pathological consequences of sequence duplications in the human genome. Genome Res. 8 (1998) 1007-1021
74. Mekeel K.L., Tang W., Kachnic L.A., Luo C.M., DeFrank J.S., and Powell S.N. Inactivation of p53 results in high rates of homologous recombination. Oncogene 14 (1997) 1847-1857
75. Meyn M.S. Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene. Clin. Genet. 55 (1999) 289-304
76. Mitelman F., Johansson B., and Mertens F. Mitelman Database of Chromosomal Aberrations in Cancer (2003). http://cgap.nci.nih.gov/Chromosomes/Mitelman
77. Moynahan M.E., Pierce A.J., and Jasin M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell 7 (2001) 263-272
78. Murphy K.M., Brune K.A., Griffin C., Sollenberger J.E., Petersen G.M., Bansal R., Hruban R.H., and Kern S.E. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: Deleterious BRCA2 mutations in 17%. Cancer Res. 62 (2002) 3789-3793
79. Nakanishi K., Yang Y.G., Pierce A.J., Taniguchi T., Digweed M., D'Andrea A.D., Wang Z.Q., and Jasin M. Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl. Acad. Sci. USA 102 (2005) 1110-1115
80. Nathanson K.L., Wooster R., Weber B.L., and Nathanson K.N. Breast cancer genetics: What we know and what we need. Nat. Med. 7 (2001) 552-556
81. Naylor J., Brinke A., Hassock S., Green P.M., and Giannelli F. Characteristic mRNA abnormality found in half the patients with severe haemophilia A is due to large DNA inversions. Hum. Mol. Genet. 2 (1993) 1773-1778
82. Naylor J.A., Nicholson P., Goodeve A., Hassock S., Peake I., and Giannelli F. A novel DNA inversion causing severe hemophilia A. Blood 87 (1996) 3255-3261
83. Nelis E., Van Broeckhoven C., De Jonghe P., Lofgren A., Vandenberghe A., Latour P., Le Guern E., Brice A., Mostacciuolo M.L., Schiavon F., et al. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: A European collaborative study. Eur. J. Hum. Genet. 4 (1996) 25-33
84. Oshima J., Huang S., Pae C., Campisi J., and Schiestl R.H. Lack of WRN results in extensive deletion at nonhomologous joining ends. Cancer Res. 62 (2002) 547-551
85. Pentao L., Wise C.A., Chinault A.C., Patel P.I., and Lupski J.R. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nat. Genet. 2 (1992) 292-300
86. Pierce A.J., and Jasin M. NHEJ deficiency and disease. Mol. Cell 8 (2001) 1160-1161
87. Pittman D.L., and Schimenti J.C. Midgestation lethality in mice deficient for the RecA-related gene, Rad51d/Rad51l3. Genesis 26 (2000) 167-173
88. Purandare S.M., and Patel P.I. Recombination hot spots and human disease. Genome Res. 7 (1997) 773-786
89. Rafii S., O'Regan P., Xinarianos G., Azmy I., Stephenson T., Reed M., Meuth M., Thacker J., and Cox A. A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer. Hum. Mol. Genet. 11 (2002) 1433-1438
90. Reichenbach J., Schubert R., Schwan C., Muller K., Bohles H.J., and Zielen S. Anti-oxidative capacity in patients with ataxia telangiectasia. Clin. Exp. Immunol. 117 (1999) 535-539
91. Reichenbach J., Schubert R., Schindler D., Muller K., Bohles H., and Zielen S. Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid. Redox Signal. 4 (2002) 465-469
92. Reliene R., and Schiestl R.H. Mouse models for induced genetic instability at endogenous loci. Oncogene 22 (2003) 7000-7010
93. Reliene R., Fischer E., and Schiestl R.H. Effect of N-acetyl cysteine on oxidative DNA damage and the frequency of DNA deletions in atm-deficient mice. Cancer Res. 64 (2004) 5148-5153
94. Reliene R., Hlavacova A., Mahadevan B., Baird W.M., and Schiestl R.H. Diesel exhaust particles cause increased levels of DNA deletions after transplacental exposure in mice. Mutat. Res. 570 (2005) 245-252
95. Richardson C., Stark J.M., Ommundsen M., and Jasin M. Rad51 overexpression promotes alternative double-strand break repair pathways and genome instability. Oncogene 23 (2004) 546-553
96. Rodriguez-Lopez R., Osorio A., Ribas G., Pollan M., Sanchez-Pulido L., de la Hoya M., Ruibal A., Zamora P., Arias J.I., Salazar R., et al. The variant E233G of the RAD51D gene could be a low-penetrance allele in high-risk breast cancer families without BRCA1/2 mutations. Int. J. Cancer 110 (2004) 845-849
97. Schichman S.A., Caligiuri M.A., Strout M.P., Carter S.L., Gu Y., Canaani E., Bloomfield C.D., and Croce C.M. ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Res. 54 (1994) 4277-4280
98. Schiestl R.H., Igarashi S., and Hastings P.J. Analysis of the mechanism for reversion of a disrupted gene. Genetics 119 (1988) 237-247
99. Schiestl R.H., Gietz R.D., Mehta R.D., and Hastings P.J. Carcinogens induce intrachromosomal recombination in yeast. Carcinogenesis 10 (1989) 1445-1455
100. Schiestl R.H., Chan W.S., Gietz R.D., Mehta R.D., and Hastings P.J. Safrole, eugenol and methyleugenol induce intrachromosomal recombination in yeast. Mutat. Res. 224 (1989) 427-436
101. Schiestl R.H., Khogali F., and Carls N. Reversion of the mouse pink-eyed unstable mutation induced by low doses of x-rays. Science 266 (1994) 1573-1576
102. Schiestl R.H., Aubrecht J., Yap W.Y., Kandikonda S., and Sidhom S. Polychlorinated biphenyls and 2,3,7,8-tetrachlorodibenzo-p-dioxin induce intrachromosomal recombination in vitro and in vivo. Cancer Res. 57 (1997) 4378-4383
103. Schiestl R.H., Aubrecht J., Khogali F., and Carls N. Carcinogens induce reversion of the mouse pink-eyed unstable mutation. Proc. Natl. Acad. Sci. USA 94 (1997) 4576-4581
104. Schmid C.W., Deka N., and Matera A.G. Repetetive human DNA: The shape of things to come. In: Adolph K.W. (Ed). "Chromosomes: Eucaryotic, Procaryotic and Viral" Vol. I (1989), CRC Press, Boca Raton 3-29
105. Scully R., and Livingston D.M. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408 (2000) 429-432
106. Shen J., and Loeb L.A. Unwinding the molecular basis of the Werner syndrome. Mech. Ageing Dev. 122 (2001) 921-944
107. Shivji M.K., and Venkitaraman A.R. DNA recombination, chromosomal stability and carcinogenesis: Insights into the role of BRCA2. DNA Repair (Amst.) 3 (2004) 835-843
108. Shu Z., Smith S., Wang L., Rice M.C., and Kmiec E.B. Disruption of muREC2/RAD51L1 in mice results in early embryonic lethality which can be partially rescued in a p53(-/-) background. Mol. Cell. Biol. 19 (1999) 8686-8693
109. Snouwaert J.N., Gowen L.C., Latour A.M., Mohn A.R., Xiao A., DiBiase L., and Koller B.H. BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene. Oncogene 18 (1999) 7900-7907
110. Strong L.C., Williams W.R., and Tainsky M.A. The Li-Fraumeni syndrome: From clinical epidemiology to molecular genetics. Am. J. Epidemiol. 135 (1992) 190-199
111. Stumm M., Neubauer S., Keindorff S., Wegner R.D., Wieacker P., and Sauer R. High frequency of spontaneous translocations revealed by FISH in cells from patients with the cancer-prone syndromes ataxia telangiectasia and Nijmegen breakage syndrome. Cytogenet. Cell. Genet. 92 (2001) 186-191
112. Sturzbecher H.W., Donzelmann B., Henning W., Knippschild U., and Buchhop S. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction. EMBO J. 15 (1996) 1992-2002
113. Taniguchi T., Garcia-Higuera I., Andreassen P.R., Gregory R.C., Grompe M., and D'Andrea A.D. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100 (2002) 2414-2420
114. Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett. 219 (2005) 125-135
115. Thompson L.H., and Schild D. Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat. Res. 477 (2001) 131-153
116. Thompson L.H., and Schild D. Recombinational DNA repair and human disease. Mutat. Res. 509 (2002) 49-78
117. Thompson L.H., Hinz J.M., Yamada N.A., and Jones N.J. How Fanconi anemia proteins promote the four Rs: Replication, recombination, repair, and recovery. Environ. Mol. Mutagen. 45 (2005) 128-142
118. Todd R., and Wong D.T. Oncogenes. Anticancer Res. 19 (1999) 4729-4746
119. Tsuzuki T., Fujii Y., Sakumi K., Tominaga Y., Nakao K., Sekiguchi M., Matsushiro A., Yoshimura Y., and Morita T. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA 93 (1996) 6236-6240
120. Tutt A., Gabriel A., Bertwistle D., Connor F., Paterson H., Peacock J., Ross G., and Ashworth A. Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr. Biol. 9 (1999) 1107-1110
121. Uziel T., Lerenthal Y., Moyal L., Andegeko Y., Mittelman L., and Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22 (2003) 5612-5621
122. Venkitaraman A.R. Chromosome stability, DNA recombination and the BRCA2 tumour suppressor. Curr. Opin. Cell. Biol. 13 (2001) 338-343
123. Vispe S., Cazaux C., Lesca C., and Defais M. Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res. 26 (1998) 2859-2864
124. Wang W., Seki M., Narita Y., Sonoda E., Takeda S., Yamada K., Masuko T., Katada T., and Enomoto T. Possible association of BLM in decreasing DNA double strand breaks during DNA replication. EMBO J. 19 (2000) 3428-3435
125. Wang X.W., Tseng A., Ellis N.A., Spillare E.A., Linke S.P., Robles A.I., Seker H., Yang Q., Hu P., Beresten S., et al. Functional interaction of p53 and BLM DNA helicase in apoptosis. J. Biol. Chem. 276 (2001) 32948-32955
126. Wang Y., Cortez D., Yazdi P., Neff N., Elledge S.J., and Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14 (2000) 927-939
127. Wijnhoven S.W., Kool H.J., van Teijlingen C.M., van Zeeland A.A., and Vrieling H. Loss of heterozygosity in somatic cells of the mouse. An important step in cancer initiation?. Mutat. Res. 473 (2001) 23-36
128. Wise C.A., Garcia C.A., Davis S.N., Heju Z., Pentao L., Patel P.I., and Lupski J.R. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication. Am. J. Hum. Genet. 53 (1993) 853-863
129. Wong A.K., Pero R., Ormonde P.A., Tavtigian S.V., and Bartel P.L. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J. Biol. Chem. 272 (1997) 31941-31944
130. Wu L., Davies S.L., Levitt N.C., and Hickson I.D. Potential role for the BLM helicase in recombinational repair via a conserved interaction with RAD51. J. Biol. Chem. 276 (2001) 19375-19381
131. Xu X., Weaver Z., Linke S.P., Li C., Gotay J., Wang X.W., Harris C.C., Ried T., and Deng C.X. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3 (1999) 389-395
132. Yen P.H., Li X.M., Tsai S.P., Johnson C., Mohandas T., and Shapiro L.J. Frequent deletions of the human X chromosome distal short arm result from recombination between low copy repetitive elements. Cell 61 (1990) 603-610
133. Yin Y., Tainsky M.A., Bischoff F.Z., Strong L.C., and Wahl G.M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70 (1992) 937-948
134. Yoshikawa K., Ogawa T., Baer R., Hemmi H., Honda K., Yamauchi A., Inamoto T., Ko K., Yazumi S., Motoda H., et al. Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas. Int. J. Cancer 88 (2000) 28-36
135. Zhang H., Somasundaram K., Peng Y., Tian H., Bi D., Weber B.L., and El-Deiry W.S. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16 (1998) 1713-1721
136. Zhou Z.H., Akgun E., and Jasin M. Repeat expansion by homologous recombination in the mouse germ line at palindromic sequences. Proc. Natl. Acad. Sci. USA 98 (2001) 8326-8333